PapersFlow Research Brief

Health Sciences · Medicine

Adipose Tissue and Metabolism
Research Guide

What is Adipose Tissue and Metabolism?

Adipose tissue and metabolism is the study of how fat depots (including white, brown, and beige adipocytes) store and mobilize energy, signal to other organs through endocrine and immune pathways, and contribute to systemic metabolic regulation and disease risk.

The research literature on adipose tissue and metabolism spans 130,191 works and emphasizes adipose endocrine function, inflammation, mitochondrial biology, and systemic energy balance. "Obesity is associated with macrophage accumulation in adipose tissue" (2003) and "Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance" (1993) anchor a mechanistic view in which adipose immune signaling contributes to insulin resistance. "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" (2017) frames adipose tissue function and body fat distribution as key determinants of cardiometabolic risk beyond total adiposity.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Physiology"] T["Adipose Tissue and Metabolism"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
130.2K
Papers
N/A
5yr Growth
2.8M
Total Citations

Research Sub-Topics

Why It Matters

Adipose tissue biology directly informs clinical strategies for obesity, diabetes, and cardiometabolic risk stratification by linking adipose dysfunction to insulin resistance and inflammatory complications. Hotamışlıgil et al. (1993) in "Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance" connected adipose-derived TNF-α to obesity-linked insulin resistance, providing a rationale for targeting inflammatory pathways in metabolic disease. Weisberg et al. (2003) in "Obesity is associated with macrophage accumulation in adipose tissue" described obesity-associated macrophage accumulation in adipose tissue, supporting the concept that immune-cell remodeling of fat is a disease-relevant tissue change rather than a bystander effect. Goossens (2017) in "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" emphasized that body fat distribution and impaired adipose tissue function help explain why individuals with similar BMI can differ in cardiometabolic risk, motivating clinical phenotyping beyond BMI. Beyond metabolic disease, Zuk et al. (2002) in "Human Adipose Tissue Is a Source of Multipotent Stem Cells" established adipose tissue as a practical source of multipotent stem cells, supporting translational applications in regenerative medicine that leverage a readily accessible tissue source.

Reading Guide

Where to Start

Start with Goossens (2017), "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function", because it defines core clinical phenotypes (fat mass, distribution, adipose function) and explains why adipose dysfunction matters for cardiometabolic risk beyond BMI.

Key Papers Explained

Zhang et al. (1994), "Positional cloning of the mouse obese gene and its human homologue", establishes an endocrine-genetic foundation for energy balance. Schwartz et al. (2000), "Central nervous system control of food intake", connects peripheral metabolic signals to neural regulation of feeding and body weight. Hotamışlıgil et al. (1993), "Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance", and Hotamışlıgil (2006), "Inflammation and metabolic disorders", frame adipose inflammation as a mechanistic driver of insulin resistance and metabolic disease. Weisberg et al. (2003), "Obesity is associated with macrophage accumulation in adipose tissue", provides tissue-level immune remodeling evidence that supports inflammatory models of adipose dysfunction. Murphy (2008), "How mitochondria produce reactive oxygen species", and Brownlee (2001), "Biochemistry and molecular cell biology of diabetic complications", connect mitochondrial/oxidative mechanisms to downstream metabolic pathology relevant to diabetes complications.

Paper Timeline

100%
graph LR P0["Positional cloning of the mouse ...
1994 · 13.3K cites"] P1["Biochemistry and molecular cell ...
2001 · 8.9K cites"] P2["Obesity is associated with macro...
2003 · 8.6K cites"] P3["Obesity is associated with macro...
2003 · 8.2K cites"] P4["Inflammation and metabolic disor...
2006 · 8.6K cites"] P5["How mitochondria produce reactiv...
2008 · 7.8K cites"] P6["The Metabolic Phenotype in Obesi...
2017 · 8.5K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P0 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

A practical advanced direction is to integrate adipose immune remodeling ("Obesity is associated with macrophage accumulation in adipose tissue" (2003)) with inflammation-centric disease models ("Inflammation and metabolic disorders" (2006)) while explicitly incorporating mitochondrial mechanisms ("How mitochondria produce reactive oxygen species" (2008)) and complication biology ("Biochemistry and molecular cell biology of diabetic complications" (2001)). Another advanced direction is to connect adipose-derived endocrine/genetic signals ("Positional cloning of the mouse obese gene and its human homologue" (1994)) to systems-level control of feeding and energy balance ("Central nervous system control of food intake" (2000)) and then reinterpret these links through clinical heterogeneity frameworks ("The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" (2017)).

Papers at a Glance

In the News

Code & Tools

Recent Preprints

Single-cell-resolved transcriptional dynamics of human subcutaneous adipose tissue during lifestyle- and bariatric surgery-induced weight loss

Jan 2026 nature.com Preprint

Human white adipose tissue undergoes major remodelling during sustained weight gain that may compromise tissue function and drive cardiometabolic comorbidities. Although weight loss reverses many o...

Single-cell DNA methylome and 3D genome atlas of human subcutaneous adipose tissue

Aug 2025 nature.com Preprint

The cell-type-level epigenomic landscape of human subcutaneous adipose tissue (SAT) is not well characterized. Here, we elucidate the epigenomic landscape across SAT cell types using snm3C-seq. We ...

A catecholamine-independent pathway controlling adaptive adipocyte lipolysis

Jan 2026 nature.com Preprint

Adipocytes classically store or release energy in response to changes in metabolic status. Specifically, white adipose tissue (WAT) and brown adipose tissue (BAT) take up and store energy in the fo...

Multi-omic definition of metabolic obesity through adipose ...

nature.com Preprint

Obesity’s metabolic heterogeneity is not fully captured by body mass index (BMI). Here we show that deep multi-omics phenotyping of 1,408 individuals defines a metabolome-informed obesity metric (m...

Adipose Tissue Insulin Resistance: A Key Driver of Metabolic Syndrome Pathogenesis

Sep 2025 mdpi.com Preprint

Metabolic syndrome (MetS), characterized by obesity, insulin resistance, dyslipidemia, and hypertension, is a growing global health concern. This review examines the relationship between adipose ti...

Latest Developments

Recent developments in adipose tissue and metabolism research include a symposium on adipocyte futile cycling and weight management scheduled for May 2026, which will explore new discoveries in adipose biology and metabolic memory (NYAS), the identification of a new role for the HSL protein in fat regulation that impacts obesity and fat-loss disorders, and advances in tissue-specific drug delivery for metabolic health (ScienceDaily, MIT), as well as insights from single-cell studies revealing transcriptional dynamics of adipose tissue during weight loss (Nature Metabolism, Cell Metabolism00038-4)), and a 2025 study on the remodeling of adipose tissue in obesity and weight loss (Nature).

Frequently Asked Questions

What is the central idea linking adipose tissue to systemic insulin resistance?

"Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance" (1993) provides a mechanistic link in which an adipose-derived inflammatory mediator (TNF-α) contributes directly to insulin resistance. "Inflammation and metabolic disorders" (2006) generalizes this concept by synthesizing inflammation as a driver of metabolic disease rather than a secondary consequence.

How does obesity change adipose tissue immune composition?

Weisberg et al. (2003) in "Obesity is associated with macrophage accumulation in adipose tissue" reported that obesity is associated with macrophage accumulation in adipose tissue. The paper frames this accumulation as part of a broader shift in adipose metabolic and endocrine function that can contribute to obesity-associated complications.

Which features of obesity best predict metabolic risk beyond BMI?

Goossens (2017) in "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" argues that body fat distribution and impaired adipose tissue function help explain heterogeneity in cardiometabolic disease risk beyond total adiposity. The review positions adipose tissue function as a mechanistic bridge between fat distribution and systemic metabolic outcomes.

How do mitochondrial processes connect to adipose-related metabolic pathology?

Murphy (2008) in "How mitochondria produce reactive oxygen species" explains mechanisms by which mitochondria generate reactive oxygen species, a process implicated broadly in oxidative damage and redox signaling. Brownlee (2001) in "Biochemistry and molecular cell biology of diabetic complications" connects biochemical mechanisms, including oxidative stress pathways, to diabetic complications, providing a conceptual route by which mitochondrial dysfunction can intersect with metabolic disease.

Which foundational discovery connects adiposity to endocrine signaling that affects metabolism?

Zhang et al. (1994) in "Positional cloning of the mouse obese gene and its human homologue" identified the obese gene and its human homologue, establishing a genetic and endocrine entry point for understanding how adiposity can influence systemic physiology. Schwartz et al. (2000) in "Central nervous system control of food intake" places such peripheral signals into a broader framework of CNS regulation of feeding and energy balance.

Which paper supports using adipose tissue for regenerative or cell-based applications, and why?

Zuk et al. (2002) in "Human Adipose Tissue Is a Source of Multipotent Stem Cells" reported that human adipose tissue contains multipotent stem cells. This supports translational use of adipose tissue as an accessible cell source for research and potential therapeutic development.

Open Research Questions

  • ? Which molecular signals determine when obesity-associated macrophage accumulation in adipose tissue becomes a causal driver of systemic insulin resistance rather than a correlate, as framed by "Obesity is associated with macrophage accumulation in adipose tissue" (2003)?
  • ? How do adipose-derived inflammatory mediators beyond TNF-α integrate with endocrine and neural control of energy balance described in "Central nervous system control of food intake" (2000) to produce persistent obesity phenotypes?
  • ? Which adipose tissue functional readouts best operationalize the risk concepts in "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" (2017) for reproducible clinical stratification?
  • ? How do mitochondrial reactive oxygen species mechanisms described in "How mitochondria produce reactive oxygen species" (2008) map onto specific pathways implicated in "Biochemistry and molecular cell biology of diabetic complications" (2001) in adipose-relevant contexts?
  • ? Which adipose-resident multipotent cell populations described in "Human Adipose Tissue Is a Source of Multipotent Stem Cells" (2002) are most relevant to adipose tissue remodeling that accompanies obesity-associated metabolic dysfunction?

Research Adipose Tissue and Metabolism with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Adipose Tissue and Metabolism with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers